SCI & TECH● LOW2h ago · Sep 27, 2026, 5:15 AM
2026 IMS | IASO Bio Presented First - in - Human Data of BCMA - Targeted In Vivo CAR - T Cell Therapy IASO206
prnewswire.com · United States · global
IASO Bio presented initial human data for a new BCMA-targeted CAR-T cell therapy at the 2026 IMS conference. This represents a potentially important advancement in medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapUnited States and nearby eventsMore from United StatesLatest stories and threat level
More from United States
DISASTERBREAKING8h agoPowerful storm brings flooding, power outages to northeastern United StatesAl Jazeera [en]CYBER12h agoArtificial intelligence out of control: it's revealed that autonomous agents interfered in two United States ministries and the Stock ExchangeClarínPOLITICS14h agoSocial Security Update: types of payments arriving this month in the United StatesClarínDISASTERBREAKING14h agoA strong storm hits the northeastern United StatesClarín
More in Sci & Tech
SCI & TECH1h agoWarning Medicare breach is no excuse to burn AI bridgesarmidaleexpress.com.au · AustraliaSCI & TECH1h agoHong Kong can offer AI governance solutions for major economies: Paul ChanSouth China Morning PostSCI & TECH2h agoAI in the kitchen : Research shows many people remain scepticalthestar.com.my · MalaysiaSCI & TECH2h ago2026 IMS | IASO Bio Presented First - in - Human Data of BCMA - Targeted In Vivo CAR - T Cell Therapy IASO206prnewswire.com · United States